{"id":"W3014578203","doi":"10.1177/0961203320917460","title":"Thrombotic microangiopathy in the course of catastrophic antiphospholipid syndrome successfully treated with eculizumab: case report and systematic review of the literature","year":2020,"lang":"en","type":"review","venue":"Lupus","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University","funders":"","keywords":"Eculizumab; Thrombotic microangiopathy; Medicine; Antiphospholipid syndrome; Catastrophic antiphospholipid syndrome; Atypical hemolytic uremic syndrome; Monoclonal; Internal medicine; Complement system; Intensive care medicine; Immunology; Monoclonal antibody; Antibody; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":{"n_in":0,"stratum":"aff_core","weight":5595.2375,"opus":{"tier":"OUT","genre":"empirical","about_ca":false,"confidence":"high","reason":"Case report plus systematic review of a drug's efficacy in a rare syndrome; clinical question."},"gpt":{"tier":"OUT","genre":"empirical","about_ca":false,"confidence":"high","reason":"This systematic review evaluates a treatment for a clinical syndrome rather than evidence synthesis methodology."},"grok":{"tier":"OUT","genre":"empirical","about_ca":false,"confidence":"high","reason":"Clinical review of eculizumab in catastrophic antiphospholipid syndrome, not metaresearch."}},"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00154338,0.0005504843,0.002320008,0.007679562,0.0003539214,0.000957065,0.0007767451,0.001047341,0.001646635],"category_scores_gemma":[0.006354535,0.0003394168,0.001802985,0.006912242,0.0004980759,0.0009474616,0.0005647455,0.0004320821,0.0001640152],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007712263,"about_ca_system_score_gemma":0.002826568,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002518036,"about_ca_topic_score_gemma":0.007631033,"domain_scores_codex":[0.9981767,0.0004489024,0.0008955207,0.0001548358,0.0002744783,0.00004956378],"domain_scores_gemma":[0.995007,0.003096037,0.001361449,0.00007946788,0.0003855298,0.00007054256],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0002778812,0.0000710535,0.0057252,0.7867037,0.007270257,0.005308974,0.0004772069,0.0002135861,0.0008843185,0.000623874,0.005450958,0.186993],"study_design_scores_gemma":[0.0002975265,0.0005936629,0.02752214,0.7011393,0.089168,0.04759909,0.001167023,0.0003316568,0.001033256,0.001100082,0.129912,0.0001363963],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001030234,0.9984237,0.00005717585,0.0001276862,0.00003793805,0.00003858343,0.000082554,0.000002375949,0.0001997572],"genre_scores_gemma":[0.01317149,0.9860107,0.0002801859,0.0002920954,0.00007090036,0.00004190544,0.00007664673,0.000001472466,0.00005450904],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.007679562,"threshold_uncertainty_score":0,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01678737012568253,"score_gpt":0.3045109584670462,"score_spread":0.2877235883413636,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}